160 related articles for article (PubMed ID: 36639831)
1. Small molecule Z363 co-regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growth.
Xiong Y; Wang L; Xu S; Fu B; Che Y; Zaky MY; Tian R; Yao R; Guo D; Sha Z; Lin F; Lin X; Wu H
Clin Transl Med; 2023 Jan; 13(1):e1153. PubMed ID: 36639831
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.
Hanoun N; Fritsch S; Gayet O; Gigoux V; Cordelier P; Dusetti N; Torrisani J; Dufresne M
J Biol Chem; 2014 Dec; 289(51):35593-604. PubMed ID: 25355311
[TBL] [Abstract][Full Text] [Related]
3. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
[TBL] [Abstract][Full Text] [Related]
4. Control of TGFβ signalling by ubiquitination independent function of E3 ubiquitin ligase TRIP12.
Keyan KS; Salim S; Gowda S; Abdelrahman D; Amir SS; Islam Z; Vargas C; Bengoechea-Alonso MT; Alwa A; Dahal S; Kolatkar PR; Da'as S; Torrisani J; Ericsson J; Mohammad F; Khan OM
Cell Death Dis; 2023 Oct; 14(10):692. PubMed ID: 37863914
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.
Larrieu D; Brunet M; Vargas C; Hanoun N; Ligat L; Dagnon L; Lulka H; Pommier RM; Selves J; Jády BE; Bartholin L; Cordelier P; Dufresne M; Torrisani J
Sci Rep; 2020 Jan; 10(1):789. PubMed ID: 31964993
[TBL] [Abstract][Full Text] [Related]
6. Transforming Growth Factor β-Induced Proliferative Arrest Mediated by TRIM26-Dependent TAF7 Degradation and Its Antagonism by MYC.
Nakagawa T; Hosogane M; Nakagawa M; Morohoshi A; Funayama R; Nakayama K
Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203640
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-dependent overexpression of c-Myc enhances CRL4
Liu H; Lu W; He H; Wu J; Zhang C; Gong H; Yang C
J Pathol; 2019 Aug; 248(4):464-475. PubMed ID: 30945288
[TBL] [Abstract][Full Text] [Related]
8. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
Guo Z; Zhou Y; Evers BM; Wang Q
Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
[TBL] [Abstract][Full Text] [Related]
9. Trip12 is an E3 ubiquitin ligase for USP7/HAUSP involved in the DNA damage response.
Liu X; Yang X; Li Y; Zhao S; Li C; Ma P; Mao B
FEBS Lett; 2016 Dec; 590(23):4213-4222. PubMed ID: 27800609
[TBL] [Abstract][Full Text] [Related]
10. TRIP12 functions as an E3 ubiquitin ligase of APP-BP1.
Park Y; Yoon SK; Yoon JB
Biochem Biophys Res Commun; 2008 Sep; 374(2):294-8. PubMed ID: 18627766
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
12. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
13.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
14. E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions.
Brunet M; Vargas C; Larrieu D; Torrisani J; Dufresne M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198194
[TBL] [Abstract][Full Text] [Related]
15. MYC protein stability is negatively regulated by BRD4.
Devaiah BN; Mu J; Akman B; Uppal S; Weissman JD; Cheng D; Baranello L; Nie Z; Levens D; Singer DS
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13457-13467. PubMed ID: 32482868
[TBL] [Abstract][Full Text] [Related]
16. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of
Lu W; Yang C; He H; Liu H
Int J Biol Sci; 2020; 16(6):1071-1085. PubMed ID: 32140074
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
18. The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway.
Park Y; Yoon SK; Yoon JB
J Biol Chem; 2009 Jan; 284(3):1540-9. PubMed ID: 19028681
[TBL] [Abstract][Full Text] [Related]
19. TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.
Seo BA; Kim D; Hwang H; Kim MS; Ma SX; Kwon SH; Kweon SH; Wang H; Yoo JM; Choi S; Kwon SH; Kang SU; Kam TI; Kim K; Karuppagounder SS; Kang BG; Lee S; Park H; Kim S; Yan W; Li YS; Kuo SH; Redding-Ochoa J; Pletnikova O; Troncoso JC; Lee G; Mao X; Dawson VL; Dawson TM; Ko HS
Neuron; 2021 Dec; 109(23):3758-3774.e11. PubMed ID: 34644545
[TBL] [Abstract][Full Text] [Related]
20. TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.
Kaiho-Soma A; Akizuki Y; Igarashi K; Endo A; Shoda T; Kawase Y; Demizu Y; Naito M; Saeki Y; Tanaka K; Ohtake F
Mol Cell; 2021 Apr; 81(7):1411-1424.e7. PubMed ID: 33567268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
